Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial
Aethlon Medical, Inc. (NASDAQ: AEMD) Delayed: 1.82 -0.11 (5.7%)
Previous Close $1.93    52 Week High $9.09 
Open $1.79    52 Week Low $4.02 
Day High $1.82    P/E N/A 
Day Low $1.70    EPS $-0.05 
Volume 163,075